Antidiabetic drugs are a group of drug structurally unrelated to sulfonylureas and are effective when used in combination with insulin or sulfonylureas. These drugs include alpha-glucosidase inhibitors, biguanides, dipeptidyl peptidase-4 (DPP-4) inhibitors, human amylin, incretin mimetics, meglitinides, and thiazolidinediones.
Antidiabetic Agents: Generic and Brand Names
Here is a table of commonly encountered other antidiabetic agents, their generic names, and brand names:
|Classifications||Generic Name||Brand Name|
|Alpha-glucosidase inhibitors||acarbose miglitol||Precose, Glyset|
|Human amylin||pramlintide acetate||Symlin|
The desired and beneficial action of other antidiabetic agents:
- Alpha-glucosidase inhibitors acarbose and miglitol inhibit alpha-glucosidase, an enzyme that breaks down glucose for absorption. Therefore, they delay the absorption of glucose. They have only a mild effect on glucose levels and do not enhance insulin secretion. They are associated with severe hepatic toxicity and GI distress.
- Biguanide metformin decrease the production and increases the uptake of glucose. It is effective in lowering blood glucose and does not cause hypoglycemia as the sulfonylureas do. It has been associated with development of lactic acidosis and GI distress.
- Meglitinides nateglinide and repaglinide are newer agents that act like sulfonylureas to increase insulin release.
- Synthetic human amylin pramlintide works to modulate gastric emptying after a meal to cause a feeling of fullness or satiety. It also prevents the postmeal rise in glucagon that usually elevates glucose levels. Human amylin is a hormone produced by beta cells in the pancreas that is important in regulating postmeal glucose levels. It should not be used when patient is unable to eat.
- Incretin mimetics exenatide and liraglutide mimic the effects of GLP-1: enhancement of glucose-dependent insulin secretion by the beta cells in the pancreas, depression of elevated glucagon secretion, and slowed gastric emptying to help moderate and lower blood glucose levels.
- DPP-4 inhibitors lina-, saxa-, and sitagliptin slow the breakdown of GLP-1 to prolong the effects of increased insulin secretion, decreased glucagon secretion, and slowed GI emptying.
- Thiazolidinediones pioglitazone and rosiglitazone decrease insulin resistance.
Other antidiabetic agents are indicated for the following medical conditions:
- Biguanide metformin is approved for use in children 10 years of age and older. It is also being used in the treatment of women with polycystic ovarian syndrome (PCOS).
- Meglitinides nateglinide and repaglinide are used to lower postprandial glucose levels because they are rapid-acting and with a very short half-life. They are taken just before meals.
- Thiazolidinediones pioglitazone and rosiglitazone are used in combination with insulin, metformin, and sulfonylureas in patients with insulin resistance.
- Bromocriptine, a dopamine agonist used to treat Parkinson’s disease was approved in 2009 as a CNS approach to treat type 2 diabetes.
Here are the characteristic interactions of other antidiabetic agents and the body in terms of absorption, distribution, metabolism, and excretion:
|Oral||Slow||2-2.5 h||10-16 h|
|T1/2: 6.2 h and then 17 h|
Contraindications and Cautions
The following are contraindications and cautions for the use of agents to control blood glucose level:
- Allergy to sulfonylureas and other antidiabetic agents. Avoid hypersensitivity reactions
- Type 1 diabetes. These patients do not have functioning beta cells and would have no benefit from the drug.
- Pregnancy and lactation. Potential adverse effect on the fetus or neonate.
Use of other antidiabetic agents may result to these adverse effects:
- Common adverse effects include hypoglycemia, lactic acidosis, GI upset, nausea, anorexia, diarrhea, heartburn, and allergic skin reaction.
- Pioglitazone is strongly linked with an increased risk of bladder cancer if it is used for over 1 year.
- Rosiglitazone is linked with increased risk of cardiovascular problems.
The following are drug-drug interactions involved in the use of other antidiabetic agents:
- decreased excretion with drugs that acidify urine
Nursing considerations are the same with sulfonylureas.
Practice Quiz: Antidiabetic Agents
1. Which of the following exerts its effect by inhibiting the enzyme that breaks down glucose for absorption?
1. Answer: A. Miglitol
The enzyme that breaks down glucose for absorption is called alpha glucosidase. Drugs under alpha glucosidase inhibitors include acarbose and miglitol.
2. This antidiabetic agent works best in patients with insulin resistance.
B. Dipeptidyl peptidase-4 inhibitors
2. Answer: C. Thiazolidinediones
Thiazolidinediones pioglitazone and rosiglitazone work by decreasing insulin resistance.
3. This antidiabetic drug is also used in women with polycystic ovarian syndrome.
3. Answer: B. Metformin
4. Which antidiabetic agent works by modulating gastric emptying after a meal to cause a feeling of fullness?
A. Incretin mimetics
C. Human amylin
4. Answer: C. Human amylin
Synthetic human amylin pramlintide works to modulate gastric emptying after a meal to cause a feeling of fullness or satiety. It also prevents the postmeal rise in glucagon that usually elevates glucose levels. Human amylin is a hormone produced by beta cells in the pancreas that is important in regulating postmeal glucose levels. It should not be used when patient is unable to eat.
5. Use of pioglitazone for over a year is linked with which condition?
5. Answer: B. Bladder cancer
Pioglitazone is strongly linked with an increased risk of bladder cancer if it is used for over one year.
Recommended resources and reference books. Disclosure: Includes Amazon affiliate links.
- Focus on Nursing Pharmacology – Easy to follow guide for Pharmacology
- NCLEX-RN Drug Guide: 300 Medications You Need to Know for the Exam – Great if you’re reviewing for the NCLEX
- Nursing 2017 Drug Handbook (Nursing Drug Handbook) – Reliable nursing drug handbook!
- Lehne’s Pharmacology for Nursing Care – Provides key information on commonly used drugs in nursing
- Pharmacology and the Nursing Process – Learn how to administer drugs correctly and safely!
- Pharm Phlash Cards!: Pharmacology Flash Cards – Flash Cards for Nursing Pharmacology
Here are other nursing pharmacology study guides:
Gastrointestinal System Drugs
Respiratory System Drugs
- Bronchodilators and Antiasthmatics
- Expectorants and Mucolytics
- Inhaled Steroids
- Lung Surfactants
Endocrine System Drugs
- Adrenocortical Agents
- Antidiabetic Agents
- Glucose-Elevating Agents
- Hypothalamic Agents
- Parathyroid Agents: Bisphosphonates, Calcitonins
- Pituitary Drugs
- Thyroid Agents
Autonomic Nervous System Drugs
- Adrenergic Agonists (Sympathomimetics)
- Adrenergic Antagonists (Sympatholytics)
- Anticholinergics (Parasympatholytics)
- Cholinergic Agonists (Parasympathomimetics)
Immune System Drugs
- Antiarthritic Drugs
- Nonsteroidal Anti-Inflammatory Drugs
- Anti-Infective Drugs
- Antineoplastic Agents
- Antiprotozoal Drugs
- Antiviral Drugs
Reproductive System Drugs
Nervous System Drugs
- Antiparkinsonism Drugs
- Antiseizure Drugs
- Anxiolytics and Hypnotic Drugs
- General and Local Anesthetics
- Muscle Relaxants
- Narcotics, Narcotic Agonists, and Antimigraine Agents
- Neuromuscular Junction Blocking Agents
- Psychotherapeutic Drugs
Cardiovascular System Drugs
- Antianginal Drugs
- Antiarrhythmic Drugs
- Antihyperlipidemic Drugs
- Antihypertensive Drugs
- Cardiotonic-Inotropic Drugs
- Drugs Affecting Coagulation
References and Sources
References and sources for this pharmacology guide for Antidiabetic Agents:
- Karch, A. M., & Karch. (2011). Focus on nursing pharmacology. Wolters Kluwer Health/Lippincott Williams & Wilkins. [Link]
- Katzung, B. G. (2017). Basic and clinical pharmacology. McGraw-Hill Education.
- Lehne, R. A., Moore, L. A., Crosby, L. J., & Hamilton, D. B. (2004). Pharmacology for nursing care.
- Smeltzer, S. C., & Bare, B. G. (1992). Brunner & Suddarth’s textbook of medical-surgical nursing. Philadelphia: JB Lippincott.